ATTD Yearbook & More

This category provides fast access to the ATTD Yearbook and useful specialist resources, including media, expert opinion articles, and a range of medical resources.

The ATTD Yearbook addresses a growing interest in the development of new and advanced technologies and devices for the treatment of diabetes which has resulted in numerous manuscripts in medical journals relating to this topic and it summarizes, in a critical way, the most important articles in the field of diabetes technology and treatments.

The 12TH YEARBOOK ON ADVANCED TECHNOLOGIES & TREATMENTS IN DIABETES (ATTD 2020 YEARBOOK) summarizes the most important articles in the field of diabetes technology, published in medical journals during the period between July 2019 to June 2020. 

The content of the ATTD 2020 Yearbook will be available free online via the ATTD 2021 website as from the start of the ATTD 2021 meeting. However, if you wish to pre-order a printed copy for EURO 65 you may do it during the registration process.

Mary Ann Liebert, Inc. is the publisher of the ATTD Yearbook and Conference Abstracts.

Please click below to download pdf copies of ATTD Yearbooks from previous years:

ATTD 2019 Yearbook

ATTD 2018 Yearbook

ATTD 2017 Yearbook

ATTD 2016 Yearbook

ATTD 2015 Yearbook 

ATTD 2014 Yearbook 

ATTD 2013 Yearbook

ATTD 2012 Yearbook

ATTD 2011 Yearbook

ATTD 2010 Yearbook

ATTD 2009 Yearbook

The ATTD 2020 Yearbook has been partially supported by:


"Periodically,a new idea, method, or tool leads to a turning point in the Management of diabetes. We believe such a moment is now upon us, brought by the 
development of reliable devices for continuous glucose monitoring (CGM)." 
Editorial by Matthew C. Riddle, Hertzel C. Gerstein, and William T. Cefalu, Diabetes Care 2017;40:1611–1613.

At ATTD 2017, an international panel of physicians, researchers, and individuals with diabetes came together for a consensus meeting and addressed the issues around continuous glucose monitoring (CGM).

Even though CGM moves beyond HbA1c measurement, there are issues such as the lack of standardized metrics for analyzing CGM data, and no clear criteria for matching patients to most appropriate glucose monitoring methodologies.

Consensus recommendations and the current understanding of how CGM results can affect outcomes are now summarizes in a publication in Diabetes Care.

View Summary:

Access the ATTD International Consensus on the Use of Continuous Glucose Monitoring.pdf (PDF)

Access the full article on the Diabetes Care website

touch endocrinology logo is an independent information resource designed to support physicians, clinicians and related healthcare professionals in continuously developing their knowledge, effectiveness and productivity, with open access articles and multimedia content.

European Endocrinology is a peer-reviewed, open access, bi-annual journal comprising review articles, case reports, practice guides, theoretical discussions, and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.

Click here to access this resource online

HRP Logo

The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini-reviews, clinical guidelines and papers on novel insights from clinical practice.

Click here to access this publication online.

Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes.
The journal also publishes ADA statements, consensus reports, clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals.
Click here to access the Diabetes Care publication online

Data at the frontiers of diabetes research are collected, systematically organized, and critically evaluated by volumes in this series. Contents are based on recent findings published in the medical literature and reflect the most advanced achievements in current clinical and experimental research on diabetes and allied disorders. By giving these data coherent organization and critical interpretation, the editor and authors of ‘Frontiers in Diabetes’ perform a major service for all scientists conducting experimental or clinical work in the field.
Click here to view the publication online.

DTT logo
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators.

Click here to access the online publication